Literature DB >> 23140253

Incomplete nonsense-mediated decay facilitates detection of a multi-exonic deletion mutation in SGCE.

J Xiao1, M A Nance, M S LeDoux.   

Abstract

Mutations in SGCE represent the major cause of the myoclonus-dystonia syndrome (DYT11), an autosomal dominant disorder of reduced penetrance. Virtually all affected individuals have myoclonus, which is concentrated in the upper extremities, neck and trunk. Over half of patients have dystonia, usually affecting the neck or arms. SGCE is maternally imprinted. Of the more than 70 SGCE mutations reported in the literature, 18 are large deletions disrupting at least one exon. Therefore, testing for exonic deletions should be considered in individuals with a classic phenotype in whom Sanger sequencing is unrevealing. However, standard methodologies for detection of exonic deletion mutations are expensive, labor intensive and can produce false negatives. Herein, we report the use of cDNA derived from leukocyte RNA to identify a deletion mutation (exons 4 and 5) of SGCE in a family with DYT11. Residual RNA from incomplete nonsense-mediated decay permitted reverse transcription to cDNA. Breakpoints of the 8939 bp heterozygous deletion were then defined with long-range polymerase chain reaction and Sanger sequencing. Use of cDNA generated by reverse transcription of leukocyte RNA can reduce the costs associated with diagnostic genetic testing and can facilitate detection of deletion mutations.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SGCE; breakpoint; deletion mutation; myoclonus-dystonia syndrome; nonsense-mediated decay

Mesh:

Substances:

Year:  2012        PMID: 23140253     DOI: 10.1111/cge.12059

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Treatment of myoclonus-dystonia syndrome with tetrabenazine.

Authors:  Angelo Y Luciano; H A Jinnah; Ronald F Pfeiffer; Daniel D Truong; Martha A Nance; Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2014-10-05       Impact factor: 4.891

2.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

3.  A novel AP4M1 mutation in autosomal recessive cerebral palsy syndrome and clinical expansion of AP-4 deficiency.

Authors:  Muhammad Jameel; Joakim Klar; Muhammad Tariq; Abubakar Moawia; Naveed Altaf Malik; Syeda Seema Waseem; Uzma Abdullah; Tahir Naeem Khan; Raili Raininko; Shahid Mahmood Baig; Niklas Dahl
Journal:  BMC Med Genet       Date:  2014-12-14       Impact factor: 2.103

4.  Delayed Diagnoses of SGCE Myoclonus-Dystonia.

Authors:  M Georgeta Varga; Nikita P Nand; Mark S LeDoux
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-07-28

5.  Population Prevalence of Deleterious SGCE Variants.

Authors:  Mark S LeDoux
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.